Welcome.

Post-doctoral research fellow
, 2007-present
Division of Gastroenterology and Hepatology
Stanford University's School of Medicine

PI: Jeffrey Glenn, Ph.D., M.D., Director, Center of Hepatitis and Liver Tissue Engineering

Ph.D. in Chemical Engineering, 2003-2006
M.S. in Material Science and Engineering, 2001-2003
Stanford University
Advisor: Curtis W. Frank, Ph.D., Director, Center for Polymer Interfaces and Macromolecular Assemblies; Senior Associate Dean, Faculty Affairs


My CV in PDF

News update!
Contact

Nam-Joon Cho (ncho at stanford.edu)
CCSR Bldg. Rm 3110, 269 Campus Dr. Stanford, CA 94305
Nam-Joon Cho's
My paper on a novel class of HCV inhibitors was accepted in Science Translational Medicine in January 2010.

Articles highlighting this work as of January 25th, 2010:

Reuters, Team finds potential path for Hepatitis C drugs
CNBC,
Team finds potential path for Hepatitis C drugs
BusinessWeek,
New treatment eyed for Hepatitis C
Agence France Presse, New research finds promising treatment for hepatitis C
ScienceDaily, Potential new class of drugs to combat Hepatitis C identified
EurekAlert,
Potential new class of drugs to combat Hepatitis C identified
The Independent (UK),
New research finds promising treatment for hepatitis C
Yahoo News,
Team finds potential path for Hepatitis C drugs
MSN Health, New treatment eyed for Hepatitis C
Health Day News, New treatment eyed for Hepatitis C
eScience News, Potential new class of drugs to combat hepatitis C identified by Stanford scientists
Inside Stanford Medicine, Potential new class of drugs to combat Hepatitis C identified by scientists, (Stanford University Cover)
BusinessWire, Potential new class of drugs to combat Hepatitis C identified by Stanford scientists,
Sharp, New Treatment Eyed for Hepatitis,
the Malay Mail, Scientists close in on hepatitis C vaccine
Topnews, Potential New Path for Hepatitis C Medicines Discovered by Scientists
San Francisco Business Times, Eiger IDs new class of hep C inhibitors
eBioNews,
Potential New Class of Drugs to Combat Hepatitis C Identified

My paper on the mechanism of an antiviral peptide's mode of action is featured in ACS Chemical Biology in December, 2009.

My paper on combined QCM-D and reflectometry measurements to understand biomacromolecular interactions is featured in Analytical Chemistry in May, 2009.

Dr. Kanazawa and I presented a review article on QCM-D principles and biological applications in the Journal of Sensors in April, 2009.

My paper on liver tissue engineering was featured on the cover of Biomedical Materials in February, 2009.
Featured in Biomedical Materials in February, 2009.
Featured in Analytical Chemistry in May, 2009.

Science Translational Medicine: Three-dimensional rendering of vesicle aggregation induced by an amphipathic, alpha helical peptide derived from the hepatitis C virus NS4B protein, as imaged by atomic force microscopy.  light brown corresponds to vesicle aggregates.


Other updates
Sep. 10: "Daze with InfollutionZERO" a live graffiti performance with the theme of infollutionZERO at the Korean National Science Museum was very successful. Please check out the press coverage of this event here.

Oct. 10: http://www.infollutionzero.org/is launched! Please check out the site. And join the infollutionZERO movement to clean the digital world for our children.

Jul. 10: Josh Jackman joined the HST doctoral program @ MIT/Harvard. Congratulations Josh!

Mar.10: Josh Jackman's paper on the binding interaction of secretory phospholipase A2 was featured in Langmuir.  Congratulations Josh!

Sep. 09: Wonjae Lee's paper on drug release profile targeting was featured in Biomaterials in September, 2009.  Congratulations Wonjae!

Jun. 09: Wonjae Lee has earned his Ph.D. in Mechanical Engineering from Stanford University.  Congratulations Wonjae!

Apr. 09: Sae-Moon Yoon's paper on QCM impedance spectra analysis is featured in the Journal of Sensors in April, 2009.  Congratulations Sae-Moon!